01099 SINOPHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 1.39X | Oper Margin | 2.7% |
|---|---|---|---|
| LT Debt/Equity | 15.1% | Net Margin | 1.2% |
| Total Debt/Equity | 96.8% | Return on Equity | 8.9% |
| Price/Book | 0.69X | Return on Assets | 1.8% |
| (HKD 18.560) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 7,497.34 | 9,979.05 | 9,558.96 | 9,489.60 | 8,529.86 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -24.9 | +4.4 | +0.7 | +11.3 | +22.0 |
| Earnings Per Share (HKD) | 2.403 | 3.198 | 3.063 | 3.041 | 2.742 |
| Earnings Per Share Growth (%) | -24.9 | +4.4 | +0.7 | +10.9 | +16.5 |
| Dividend Per Share (HKD) | 0.739 | 0.956 | 0.900 | 0.872 | 0.839 |
| P/E* (X) | 7.73 | 5.80 | 6.06 | 6.10 | 6.77 |
| Yield (%) | 3.98 | 5.15 | 4.85 | 4.70 | 4.52 |
| Dividend Share (%) | 30.76 | 29.90 | 29.38 | 28.68 | 30.62 |
| Book NAV (HKD) | 26.883 | 26.342 | 24.456 | 24.255 | 21.434 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-06 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 286,043 | 294,727 | -2.9 | 300,950 |
| Operating Result | 6,510 | 6,957 | -6.4 | 8,147 |
| Associates | 687.853 | 624.719 | +10.1 | 574.277 |
| Profit Before Taxation | 7,210 | 7,596 | -5.1 | 8,866 |
| Taxation | 1,873 | 1,697 | +10.4 | 1,973 |
| Profit /( Loss) After Taxation | 5,337 | 5,899 | -9.5 | 6,893 |
| Minority Interests | 1,872 | 2,195 | -14.7 | 2,789 |
| Net Profit | 3,466 | 3,704 | -6.4 | 4,104 |
| Earnings Per Share () | 1.2168 | 1.2756 | -4.6 | 1.4194 |
| Announcement Date | 2025-08-22 | 2024-08-26 | NA | 2023-08-28 |
* Annualised
Last Update Time: 2025-09-06 21:40:25
